NEUROKININ AND NMDA ANTAGONISTS (BUT NOT A KAINIC ACID ANTAGONIST) ARE ANTINOCICEPTIVE IN THE MOUSE FORMALIN MODEL

被引:145
作者
MURRAY, CW
COWAN, A
LARSON, AA
机构
[1] UNIV MINNESOTA, DEPT VET BIOL, 295 ANIM SCI BLDG, 1988 FITCH AVE, ST PAUL, MN 55108 USA
[2] TEMPLE UNIV, HLTH SCI CTR, SCH MED, DEPT PHARMACOL, PHILADELPHIA, PA 19140 USA
关键词
FORMALIN TEST; TONIC PAIN; NEUROKININS; EXCITATORY AMINO ACIDS; SUBSTANCE-P ANTAGONISTS; DL-2-AMINO-5; PHOSPHONOVALERATE;
D O I
10.1016/0304-3959(91)90135-K
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
While much evidence implicates substance P (SP), an endogenous neurokinin (NK), as a primary sensory transmitter of acute pain in mammalian spinal cord, its role in continuous (tonic) pain is less clear. Although glutamate is co-localized with SP in dorsal root ganglion neurons, its role in nociceptive processing is uncertain. While antagonists of NKs and excitatory amino acids (EAAs) have been found to be antinociceptive in some acute assays, they have not been tested against tonic pain. We hypothesize that: (1) NKs and EAAs contribute to signaling of tonic chemogenic nociception; and (2) interaction between NK and EAA systems is important in determining the perceived intensity of a continuous noxious stimulus. We therefore evaluated two NK antagonists ([D-Pro2,D-Trp7.9] SP (DPDT-SP, 0.26-6.6 nmoles, non-specific) and [D-Pro4,D-Trp7,9,10,Phe11]-SP(4-11) (DPDTP-octa, 1.6-12.3 nmoles, somewhat NK-1 selective)), as well as DL-2-amino-5-phosphonovalerate (DL-AP5, NMDA antagonist, 0.05-1 nmole) and urethane (a kainic acid (KA) antagonist at 2.5-mu moles) for antinociceptive activity in the mouse formalin model. Administered intrathecally (i.t.), DL-AP5 and both NK antagonists were significantly antinociceptive while urethane (2.5-mu moles) and naloxone (2.7 nmoles) were inactive. A50 values for mean % analgesia, nmoles/mouse i.t. (95% CLs) were: DPDT-SP, 1.1 (0.79-1.6); DPDTP-octa, 3.9 (2.4-6.1); DL-AP5, 0.29 (0.16-0.71). The antinociception associated with 1.3 nmoles of DPDT-SP was not reversed by co-administering 2.7 nmoles of naloxone. Co-administration of 0.1 nmoles of DL-AP5 with either 1.3 nmoles of DPDT-SP or 3.3 nmoles of DPDTP-octa did not lead to additive antinociception. One nmole of DL-AP5 also produced significant antinociception in the mouse tail-flick test. These data support the contention that NK (probably NK-1) and NMDA (but not KA) receptors are involved in spinal processing of tonic chemical/inflammatory nociception in mice.
引用
收藏
页码:179 / 185
页数:7
相关论文
共 59 条
[1]   PHENCYCLIDINE SELECTIVELY BLOCKS A SPINAL ACTION OF N-METHYL-D-ASPARTATE IN MICE [J].
AANONSEN, LM ;
WILCOX, GL .
NEUROSCIENCE LETTERS, 1986, 67 (02) :191-197
[2]  
AANONSEN LM, 1987, J PHARMACOL EXP THER, V243, P9
[3]   MORPHINE ANALGESIA IN THE TAIL-FLICK AND FORMALIN PAIN TESTS IS MEDIATED BY DIFFERENT NEURAL SYSTEMS [J].
ABBOTT, FV ;
MELZACK, R ;
SAMUEL, C .
EXPERIMENTAL NEUROLOGY, 1982, 75 (03) :644-651
[4]   APPARENT LACK OF TOLERANCE IN THE FORMALIN TEST SUGGESTS DIFFERENT MECHANISMS FOR MORPHINE ANALGESIA IN DIFFERENT TYPES OF PAIN [J].
ABBOTT, FV ;
FRANKLIN, KBJ ;
LUDWICK, RJ ;
MELZACK, R .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1981, 15 (04) :637-640
[5]   NONCOMPETITIVE ANTAGONISM OF MORPHINE ANALGESIA BY DIAZEPAM IN THE FORMALIN TEST [J].
ABBOTT, FV ;
FRANKLIN, KBJ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1986, 24 (02) :319-321
[6]   MORPHINE ANALGESIA AND TOLERANCE IN THE TAIL-FLICK AND FORMALIN TESTS - DOSE-RESPONSE RELATIONSHIPS [J].
ABBOTT, FV ;
MELZACK, R ;
LEBER, BF .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1982, 17 (06) :1213-1219
[7]   THE FORMALIN TEST - A TONIC PAIN MODEL IN THE PRIMATE [J].
ALREJA, M ;
MUTALIK, P ;
NAYAR, U ;
MANCHANDA, SK .
PAIN, 1984, 20 (01) :97-105
[8]   PEPTIDES AND THE BLOOD-BRAIN-BARRIER - LIPOPHILICITY AS A PREDICTOR OF PERMEABILITY [J].
BANKS, WA ;
KASTIN, AJ .
BRAIN RESEARCH BULLETIN, 1985, 15 (03) :287-292
[9]   COEXISTENCE OF GLUTAMATE AND SUBSTANCE-P IN DORSAL-ROOT GANGLION NEURONS OF THE RAT AND MONKEY [J].
BATTAGLIA, G ;
RUSTIONI, A .
JOURNAL OF COMPARATIVE NEUROLOGY, 1988, 277 (02) :302-312
[10]  
BOWSHER D, 1978, ANAESTHESIA, V33, P935